IOL Chemicals and Pharmaceuticals Limited

Geographical Location Map

Barnala
 Mile Stones Crossed
• 1986 – IOLCP Established

• 1991 – Commenced Acetic Acid Production

• 1996 – Commissioned Ethyl Acetate Plant

• 1999 – Commenced Acetic Anhydride Production

• 2000 – Commissioned Ibuprofen Plant

• 2006 – Commissioned Power Cogeneration

 Product Range
Active Pharmaceutical Ingredients
Ibuprofen
Proton Pump Inhibitors (PPI’s) (Proposed)

Chemical Products

Acetic Acid
Ethyl Acetate
Acetic Anhydride
MCA & Acetyl Chloride
IBB
 Capacity By Product

80000 4000

70000

60000 3000
Capacity ( TPA )

50000

40000 2000
30000

20000
1000
10000

0
Acetic Ethyl Acetic 0
Acid Acetate Anhydride Ibuprofen

Products
 450
Revenues
400 361
334
350

300
Rs in Crores

232
250

200 174

150
97
100

50

0
2004-05 2005-06 2006-07 2007-08 2008-09
USD 20 mln USD 36 mln USD 48 mln USD 75 mln USD 70 mln

Years
 Operating Profit
40 37
35
35

30
R s in C ro res

25
18 19
20

15
9
10

0
2004-05 2005-06 2006-07 2007-08 2008-09
USD 1.8 mln USD 3.8mln USD 3.9 mln USD 7.7 mln USD 7.2 mln

Years
 Net Profit After Tax
14 12.69
12.36

12

10
Rs in Crores

7.26 7.55
8

4 2.55

0
2004-05 2005-06 2006-07 2007-08 2008-09
USD 0.53 mln USD 1.51 mln USD 1.57 mln USD 2.57 mln USD 2.64 mln

Years
Revenue Distribution By Product (%)
45
40
35
30
% Turnover

25
20
15
10
5
0
Ibuprofen Acetic Acid Ethyl Acetate Acetic
Anhydride

Products
 Export Sales
55 50
50
44
45
40
R s in C ro res

35
30
23
25
20
13
15
10
2
5
0
2004-05 2005-06 2006-07 2007-08 2008-09
USD 0.41 mln USD 2.70mln USD 4.79 min USD 10.4 min USD 9.16mln

Years
 GROWTH - Projects Under
Implementation
• Recently increased Ibuprofen capacity from 1800
TPA to 3600 TPA .

• Currently implementing projects for Capacity

Expansions, Forward & Backward Integration & Power
Cogeneration, involving a capital expenditure of Rs
256 Crores (approx USD 53.3 million).

• Commencing a new project for the production of

PPI’s i.e. Rabiprazole, Omeprazole, Pantoprazole
Esomeprazole and Lansoprazole in Jan 2010 at a cost
of Rs 100 Crores ( approx USD 20.83 million).
 Under Implementation Projects Contd…
Expected
Existing Proposed Completion
Product UOM Capacities Capacities Date
Capacity Enhancement      
Acetic Acid TPA 50000 75000 Nov,2009
Acetic Anhydride TPA 12000 18000 Nov,2009
Ethyl Acetate TPA 33000 36000 Nov,2009
Ibuprofen TPA 3600 6000 Dec., 2009
Cogeneration MW 4 17 Nov,2009
Backward Integration      
Iso Butyl Benzene
(Used as RM For Ibuprofen) TPA - 6600 Nov,2009
Forward Integration      

Monochloroacetic Acid TPA - 7200 Nov,2009

Acetyl Chloride Nov,2009

Acetic Anhydride as RM End use in Ibuprofen TPA - 5200
Upcoming Projects
PPI’s TPA - 480 March , 2011
 Co-generation

Expanding captive power cogeneration

capacity to 17 MW, from 4 MW currently

Present captive energy generation include

Steam and Power Generation
Monochloroacetic Acid & Acetyl
Chloride
Acetic
Process Flow
Acetic Acid
Anhydride

HCl Acetic Acid Chlorine Gas

(By Product)

HCl
(By Product)

Acetyl Chloride MCA

 Uses of Iso-Butyl Benzene
IBB PLANT

IBB SPENT GAS HIGH LOW POTASIUM

HYDRO HYDRO CARBONATE
CARBON CARBON

CAPTIVE MARKET ACETIC THERMO THERMO CO- MARKET ACETIC THE MARKET
CO- ACETIC REUSE
CONSUMP END IN IBB
ANHY PACK GEN ANHY
TION PACK GEN ANHY PACK PROCE
DRIDE DRIDE DRIDE SS
Projected Capacity Fiscal Year 2011-
12 Then Potential
Product UOM Capacities Capacities
Capacity Enhancement      

Acetic Anhydride TPA 18000 33000

Ethyl Acetate TPA 36000 50000

Ibuprofen TPA 6000 8000

Iso Butyl Benzene TPA 6600 10000

Monochloroacetic Acid TPA  7200  10000 

Acetyl chloride TPA 5200 8000

ALL OF THESE PROJECTS WILL HAVE TO BE FINANCED FROM

INTERNAL ACCRUALS AND TERM DEBT WITHOUT FURTHER DILUTION
IN EQUITY. THIS WILL RESULT IN SIGNIFICANT GROWTH IN
PROFITABILITY AND EARNINGS PER SHARE
 Global Market Presence
The various international markets catered till date include:

1.BANGLADESH 15.IRAN 29.SPAIN 43.ITALY

2.EGYPT 16.VEITNAM 30.PHILIPPINES 44.MAURITIUS
3.UGANDA 17.KUWAIT 31.CHILE 45.CHILE
4.SYRIA 18.GERMAN 32.ZIMBABWE 46.TAIWAN
5.AUSTRALIA 19.COLOMBIA 33.URUGUAY 47.TASMANIA
6.DUBAI 20.SINGAPORE 34.GHANA 48.OMAN
7.PAKISTAN 21.HONG KONG 35.TURKEY 49.COLOMBIA
8.THAILAND 22.MALAWI 36.CHINA 50.SOUTH AMERICA
9.MALAYSIA 23.BRAZIL 37.CONGO 51.YEMEN
10.BOLIVIA 24.SOUTH KOREA 38.SUDAN
11.MEXICO 25.PERU 39.NIGERIA
12.VENEZUELA 26.GUATEMALA 40.KENYA
13.ALGERIA 27.NEPAL 41.NEW ZEALAND
14.LATAVIA 28.DENMARK 42.SRI LANKA
Our Products - Our
Pride
 Ibuprofen
• Non-Steroidal Anti – Inflammatory Drug (NSAID)

• Reduces Hormones Causing Inflammation & Pain in Body

• Usage in Treatment of Variety of Ailments

• Grades Available :

- IP / BP /USP / EP /JP
- Micronized
- Dexibuprofen
- DC ( Directly compressible )
 Applications & End Usage - Ibuprofen

Application End Use User

Aristo Pharmaceuticals
Inflammation
Ltd

Sri Krishna
Acute / Chronic Pains
Pharmaceuticals Ltd

Pharma Industry as an Rheumatoid Pain Tablets India Limited

NSAID ( Non- steroidal Anti -
inflammatory Drug )
Primary Dysmenorrhea Indoco Remedies Limited

Post Operative Pain Fourrts Lab Limited

Fever Strides Arcolabs ltd

 Indian Scenario - Ibuprofen

10000

9000

8000
Capacity (In MT)

7000

6000

5000
PRODUCTION (MT)
4000 CONSUMPTION (MT)
EXPORT FROM INDIA
3000

2000

1000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Global Production – Ibuprofen

30000

25000

20000
In MT

15000

PRODUCTION (MT)
10000

5000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Ibuprofen Production Capacities - IOLCP

8000

7000
6000
6000
Production (TPA)

5000
3600
4000

3000
1800
2000
600 720
1000

0
2000-01 2005-06 2006-07 2007-08 2009-10
Year
 Ibuprofen - Market Share
Domestic Market Global Market

Satyadeept Others
Others Albemarle,
ha 7% 15% USA 17%
5% Hubei,China
13%
Shasun
IOLCP BASF, UK
48% 13% 20%
Zhongtianheng Shasun,India
di,China 16%
IOLCP 7%
37% Satwik
3%

Indian Market Global Market

8000 MT per Annum 25,000 MT per Annum
 Acetic Acid
• Acetic Acid or Ethanoic Acid Commonly Known as Vinegar

• Sour Taste & Pungent Smell

• Widely used as Chemical Reagent & Industrial Chemical

• Derivatives application almost in all fields

 Applications & End Usage –Acetic
Application
Acid End use
Eg. In the preparation of
User
IPCA, CADILA ,SR Drugs &
As in preparation of
Sulphamethoxazole, Chloroquin, Intermediates Ltd,Avon
Pharmaceuticals
Metronidazole etc. Organics Ltd
Reliance , Indian Oil ,
As in Polyester Staple In making Purified telepthalic
Mitsubishi Chemical
Fiber industries acid (PTA)
Corporation
As Acidulant & Eg: Vinegar, Jams, Pickles, Cremica , Nestle ,Bonn
Preservative Ketchups etc industries ltd,

Eg. Cellulose acetate, Ethyl IOLCP, Ester India ltd,

As in preparation of
Acetate, Zinc acetate, Amyl Shatabdi Chem. Pvt Ltd,
Acetates
acetate etc Kashyap Organics Ltd

Farmson, Swati, Reliance

Cellulose products
For e.g. Monochloroacetic acid
As a Chemical synthesize Ltd,S.R.Drugs and
(MCA) *, Vinyl Acetate Monomer
solvent Intermediates (P) Ltd,Sree
(VAM)
Rayalaseema Hi-Strength
Hypo Ltd,Karnavati Chemical

*IOLCP is Entering into the Manufacturing of MCA with the Capacity of 7200
TPA.
Applications & End Usage- Acetic Acid
Application End use User

Aimco Pesticides Ltd,Bharat

Rasayan Ltd,Meghmani
As an intermediate in
Eg. Chlorpyriphos, Acephate Organics Ltd,Rallis India Ltd,
Pesticides
Gujarat Ltd,United
Phosphorous Ltd

Colourchem Ltd.,Mumbai
Eg. Monomethyl acetoacetamide,
Diketene & its ,Indian Dyestuff
ethyl acetoacetamide, Methylaceto
derivatives Industries,Gujarat ,Avon
Acetate
Organics Ltd., Hyderabad

Laundry sour, printing calico & Nahar spinning , Vardhman ,

As Tanning agent
dyeing JCT

Turpentine and Oil Co,

As Reaction Solvents For gums, resins & volatile oils
Camphor and allied Co
Indian Scenario – Acetic Acid
700000

600000
Capacity (In MT)

500000

400000

300000 PRODUCTION (MT)

CONSUMPTION (MT)
200000

100000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Global Production – Acetic Acid
10000000

9000000
Capacity (In MT)

8000000

7000000

6000000

5000000

4000000 PRODUCTION
(MT)
3000000

2000000

1000000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Acetic Acid Production Capacities -
85000
IOLCP
75000
75000

65000
Production (TPA)

55000 50000

45000
30000
35000

25000 18000
13500
15000 7500
4500
5000

-5000
1991-92 1997-98 1998-99 2004-05 2005-06 2006-07 2008-09
Year
Captive Consumption Vs Merchant
Sales –Acetic Acid
100

90
Quantity Percentage

80

70

60

50
Captive Consumption
40
Merchant Sales
30

20

10

0
2004-05 2005-06 2006-07 2007-08 2008-09

Years
Acetic Acid – Market Share
Domestic Market Global Market

Celanese
Others 24%
JR Agro Wujing 4.4%
7%
6% GNFC
Somaiya
39%
7%

Jubilant IOLCP
28% Azot 3% BP Aramco
13%
Eastman3% Diacel 4% 23%
Millennium 4%

Indian Market Global Market

4,50,000 MT per Annum 92,00,000 MT per Annum
 Ethyl Acetate
• Ethyl Acetate or Ethyl Ethanoate – Fragrant, Colorless
Liquid

• Diverse Industrial Application as Solvent

• Usage as Synthetic Fruit Essence

• Flavor in Pharmaceuticals

• Coextractant of Camphor, Fats, Oils & Antibiotics

• Ability to replace Aromatic Solvents like Toulene,

Xylene & Methyl Isobutyl Ketone.
 Applications & End Usage – Ethyl
Application End use User
Acetate
As Lacquer sandling sealer,
Glasswood lacquer, Lacquer Inks & Paints
Berger Paints India, Goodlac
Nerolac Paints Ltd, Resins &
thinner, LP inks, quickset inks, Industry Solvents,Camlin Ink Pvt Ltd,Kores
heatset & coldset inks etc India
Uflex Ltd , Dharmapal Satyapal
As a media Solvent / wraper Flexible Packaging
industries , PG foil Ltd ,Cosmo films
shining and protection & lamination
ltd,Essel packaging
Converter & Adhesives Chemicals
For production of Glues etc. Adhesives
Ltd
Rantidine HCL IPCA, CADILA ,SR Drugs &
In Pharmaceutical Sulphamethoxazole Intermediates Ltd,Avon Organics
etc Ltd,Shasun
For creating lustre in photgraphic Photographic Films
Kodak 
films to last long & Plates
Solvents for nitrocellulose
lacquers , varnishes and Surface coatings
Godrej,Schenectedy,Bakelite Hylam
thinners.Least toxic of organic and thinners
solvents
Extensively used in the preparation
Flavours and Privi Organics, Vadilal Industries
of synthetic fruit essences,
essences Ltd , Narula foods
flavours and perfumes
Indian Scenario- Ethyl Acetate
300000

250000
Capacity (In MT)

200000

150000
PRODUCTION (MT)
CONSUMPTION (MT)
100000

50000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Global Production- Ethyl Acetate
2500000
Capacity (In MT)

2000000

1500000

1000000 PRODUCTION (MT)

500000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Ethyl Acetate Production Capacities -
40000
IOLCP
36000
33000
35000

30000
Production (TPA)

25000
18000
20000

15000

10000 6300
5100
3000
5000

0
1996-97 2000-01 2004-05 2005-06 2006-07 2008-09
Year
 Ethyl Acetate - Market Share
Domestic Market Global Market

Others
Dhampur
11%
4% BP Aramco Celanese
13% 12%

JR Agro Jubiliant Shandang

5% 41% 6%
Somaiya
8% Others
Showa Denko
54%
9%
Laxmi IOLCP Rhodia Brazil
Organics 6%
16%
15%
Indian Market Global Market
1,90,000 MT per Annum 14,00,000 MT per Annum
 Acetic Anhydride
• Ethanoic Anhydride or Acid Anhydride

• Declared As “Controlled Substance” under the

Narcotics Drugs & Psychotropic Substances (NDPS)
Act 1985 by Narcotics Control Bureau, India

• Usage in Pharmaceutical, Agrochemical, Dyes &

Pigments, Cellulose Acetate Production
Applications & End Usage-Acetic
Anhydride
Application End use
Eg. In the making of
User

Sri Krishna Pharmaceuticals Ltd ,Triton

Drugs & Paracetamol, Aspirin,
Laboratories Ltd, Ltd,Granules India ,
Pharmaceuticals Caffeine, Theophylline,
Kudos Chemie
Ephedrine HCl

Aimco Pesticides Ltd,Bharat Rasayan

Agrochemicals E.g. Acephate Ltd,Meghmani Organics Ltd,Rallis India
Ltd, United Phosphorous Ltd

Maschmejir Aromatics (India) Ltd

Perfume Industry E.g. Acetanilide ,Hindustan Polyamide,Camphor & Allied
Products, Gujarat
As an reactive E.g. Vinyl Acetate Jubliant Organysys Ltd, Vinyl Chemicals
agent Monomer  Ltd

Gujarat Industrial Chemicals Corporation,

Gwalior Chemical Industries Ltd, Indu
Dyestuff & Organic Chemicals, Amarjas Chemicals,
E.g. Acetyl Chloride*
Intermediaries Praveen Organics

*IOLCP is installing the Manufacturing Plant of Acetyl Chloride with the

Capacity of 5200 TPA.
 Indian Scenario-Acetic
Anhydride
80000

70000
Capacity (In MT)

60000

50000

40000
PRODUCTION (MT)
30000 CONSUMPTION (MT)

20000

10000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
 Global Production- Acetic
300000
Anhydride
250000
Capacity (In MT)

200000

150000

PRODUCTION (MT)
100000

50000

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
Acetic Anhydride Production Capacities -
20000
IOLCP 18000
18000
16000
Production (TPA)

14000
12000
12000
10000
7500
8000
6000 4500

4000
2000
0
1998-99 2005-06 2006-07 2008-09
Years
 Acetic Anhydride - Market Share
Domestic Market Global Market

Rhodia 5%
Jilin 5% Eastman
Dhampur
Luna 2% 33%
23%
Jubiliant Accordis 5%
47%
BP Aramco
10%
IOLCP
27%
Diacel Celanese
11% 24%

Indian Market Global Market

55,000 MT per Annum 2,00,000 MT per Annum
 Upcoming Projects
MCA & Acetyl Chloride

1. Producing MCA without using hydrogenation.

2. MCA Plant is equipped with bubble cap graphite
distillation Column instead of packed column.
3. Plant is equipped with Scrubbing System to take
care of Environment Aspects.
4. In the Plant 900 critical parameters controlled by
DCS for maintaining product quality and quantity
Contd..
5.Plant is based on forward and backward
integration of existing products.
6.Acetyl Chloride is manufactured with HCL root
instead of other root to reduce its cost and
byproduct.
7.Process Parameters are designed using Simulation
Software “CHEMCAD” Supplied by Chemstations
USA.
8.Equipped with Teflon coated pipe and fitting to
minimize maintenance problem.
 Iso Butyl Benzene
1.IBB Plant is equipped with
Pneumatic transfer System
instead of pumps to save
power.
2.In the Plant 1400 Critical
parameters controlled by
DCS to maintain product quality and Yield.
3.In the Plant Air Compressors are equipped with
Variable Frequency to get Energy Efficiency.
4. IBB Plant is the Backward integration of existing
product of IOLCP.
Manufacturing & Consumption (India)
( MCA, IBB, Acetyl Chloride )
120000

100000
Capacity (TPA)

80000
Manufacuters
60000
Consumption

40000

20000

0
MCA IBB Acetyl Chloride

Products
 Manufacturer's in India…
MCA Acetyl Chloride IBB
S.R Drugs and
Intermediates Ltd Excel Industeries Limited Vinati Organics
Reliance Cellulose Aqua Pharma SI Group
Meridian Chem-Bond Gwalior Chemicals India
Ltd Ltd
Anugrah In-Org ( P ) Ltd Sanghvi Organics Pvt Ltd
Kanrnavati Seem Products
Rencal Chemicals India
A.V.Organosys Ltd
Misc-Others
Abhishek Impex
Deedy Chem
Maruti Organics
ACI Ind

Swati Chemicals
 Upcoming Diversification Plans
Anti-ulcerants-
Proton Pump Inhibitors (PPI’s)
• The company has planned for installation of new
manufacturing facilities of PPIs- i.e. Rabiprazole,
Omeprazole, Esomeprazole, Lansoprazole & Pantoprazole .
• Rabiprazole is used to treat conditions where the stomach
produces too much acid, including ulcers,
gastroesophageal reflux disease (GERD), and Zollinger-
Ellison syndrome.
• The total amount of Capital Expenditure will be about Rs
100 Crores ( approx USD 20.83 million).
• The Project of Rabiprazole is planned to be implemented
from 2009-10.
 Proton Pump Inhibitors (PPIs)
• Bind to Proton Pump and Prevent it from Producing Acid in to the
Stomach.

• Usage in Treatment of Variety of Gastric Ailments.

• Generally have More Potent Effect on Suppressing Acid than H-2

Blockers ( like Ranitidine, Cimetidine, Nizatidine ).

• PPI’s Available :
- Rabeprazole
- Lansoprazole
- Omeprazole
- Pantoprazole
- Esomeprazole
 Comparison of PPIs and Antacids
PPIs: ANTACIDS:
Prevent Secretion of Gastric Acid by Neutralize Gastric Acid. e.g. Aluminium
Inhibiting Proton Pump in Stomach. Hydroxide & Magnesium Hydroxide.

Their Onset of Action is comparatively They Provide Faster Relief from

late but have comparatively very Long Heartburn but have very Brief
Duration of Action. Duration of Action.

Work in Gastric Lumen. So Useful in Work almost in Esophageal Lumen

Almost All Gastric Ailments. which Limits its Use only for
Spontaneous Relief from Heartburn.

Very Low Rate of Recurrence of Disease. Rate of Recurrence of Disease is

Higher.

Ref: www.medscape.com/viewarticle/464898
 Comparison of PPIs and H-2 Blockers
PPIs: H-2 Blockers:
Prevent Secretion of Gastric Acid by Prevent or Block Histamine from
Inhibiting Proton Pump in stomach. Stimulating the Production of Acid. e.g.
Cimetidine, Famotidine, Nizatidine &
Ranitidine.

Works at the Site where Acid is being Works at the Site which Stimulates the
made. That’s why More Effective in Production of Gastric Acid.
Suppressing Gastric Acid secretion
Longer Duration of Action, more than Duration of Action is 2-3 hrs
24 hrs.
Comparatively More Efficacious in Comparatively Less Efficacious in
Treatment of GERD, Gastric Ulcers and Treatment of GERD, Gastric Ulcers and
Healing of Erosive Esophagitis Healing of Erosive Esophagitis.

Dose is 20 mg / day. Usual Dose is 300 mg / day, but Long

Term 150 mg / day

1.Am J Gastroenterol. 2000 Apr;95(4):936-42; 2. Dig Dis Sci. 2001 Mar;46(3):587-96

3. ISSN 1007-9327 CN 14-1219/R World J Gastroenterol 2005 July 14;11(26):4067-4077
 Applications & End Usage- PPIs

Application End Use User

Dyspepsia Dr Reddys Lab.

Peptic ulcer Disease Cipla

Pharma Industry as an GERD / GORD Mankind

ANTI- ULCER Drug
Zollinger - Ellison Syndrome Lupin Labs.

Gastrinomas Aurobindo Pharma

Barrett’s Syndrome Nicholas

 Indian Scenario of PPIs
1800

1600

1400
Capacity (In MT)

1200

1000

800 PRODUCTION (MT)

CONSUMPTION (MT)
600

400

200

0
2005-06 2006-07 2007-08 2008-09 2009-10

Years
 Global Scenario of PPIs
14000

12000

10000
Capacity In MT

8000

Production
6000

4000

2000

0
2005-06 2006-07 2007-08 2008-09 2009-10
Years
 Growth Potential
• Potential for growth of these products is demonstrated
by their growing usage in various industries.
• While the demand growth is being accompanied by an
increase in production capacities, there is still a
significant projected demand – supply gap for these
products in the market.
• Ethanol, major raw material, available in abundance
from Distilleries of Punjab & UP.
• Company’s markets for these products are being
significantly enhanced with the commencement of
Indian Oil’s Refinery nearby at Panipat & from another
upcoming HPCL-Mittal Refinery nearby at Bhatinda
 Organisation Chart
Chairman cum
Managing Director
Varinder Gupta

Executive Vice President

Vice President Vice President Sr. Company
Director Finance &
Commercial Purchase Secretary
N K Pundir J K Bajaj Accounts Krishan Singla
R K Thukral Rakesh Mahajan

Vice President Vice President

Manager Manager Manager Company
Production Production
Domestic Sales Purchase Project Secretary
Chemicals Pharmaceuticals
Chetan Asthana Himanshu Arya Rohit Sharma Sushil Sharma
Damandeep Singh Vijay Singla

Vice President
Vice President Manager Manager
R&D Manager Legal
Co-Generation Export Sales Finance
Quality Control Gurinder Singh
Tripinder Singh Ravi Mahant Ajay Latawa
Ravi Sharma

Sr. Manager
Sr. Manager Manager
HRM
Utilities Accounts
Anil Kathuria
Deepak Saini Pardeep Khanna

Manager
Electrical Manager
Gaurav Bannerjee Instrumentation
Gopal Singla
 Manpower
100%

80%

60%
Professionals

Post Graduate
40%
Graduate

20% Diploma & Others

0%
al

RM

D
n
e
nc

io
tio
ci

&
R
H

at
er
na

uc

ul

&
m
Fi

od

m
om

y
lit
&

Si
Pr
C

ua
cc

Q
A
 Recognition

Awarded with “2nd National Energy Conservation Award”

Consecutively for the Years 2005, 2006,2007 & 2008
By Ministry of Power, Government of India
 Commitment to Quality

• The Company is committed to utilizing state-of-the-

art and globally competitive technology in its
manufacturing and processing facilities.

• High Quality Products with Quality Checks at each

and every stage, starting from Raw Material to
Finished products with latest Technology
Instruments.
 Certifications
• Certificate of Pharmaceuticals Product-WHO for Ibuprofen.

• Certificate of Foreign Drug Manufacturer from Japan.

• Koshar Certificate for all finished products

• Halal Committee Registration Certificate for Finished products

• ISO 9001:2008 for Quality Management System

• ISO 14001:2004 for Environmental Management System

• Certificate for Foreign Trade Policy-STAR EXPORT HOUSE

 Corporate Ethics
The company believes that adherence to the
corporate ethics and transparent working results
in substantial and sustainable improvements in
the performance. The Company has adopted the
following practices :

• Code of Corporate Governance & Conduct

• Code to Prevent the Insider Trading
• Code of Corporate Disclosure of Insider Trading
• Whistle Blower Policy
 Process Automation
Distribution Control Based
Operations
-Complete Automation of Process
- Computerized Parameter recording
- Better control of Process Parameters
- Operations on single mouse click
Our Technical Specializations
REACTION

SEPARATION

DISTILLATION
 Research & Development
 Equipped with latest infrastructure
 Highly competent research team
 Manufacturing technology for all the products
developed in-house
 Capacity to produce single to multi-kilogram
quantities of organic compounds
 Pilot plant studies for new products /
molecules
 ChemCAD (Simulation Software)
 Energy Saving Measures
• Energy Conservation - Major Emphasis Area

• The most cost effective way for sustainable energy

development is by improving end-use efficiency.

• We Utilize Waste Process Energy to produce

660 TR/Day of Chilled Water generated through VAM
Machines.
 Environment Friendly Plant

Untreated Effluent Treated Effluent Standard

pH 4.0 - 5.0 7.0 – 8.0 7.0 - 8.0
TDS (mg/L) 2100 - 2500 1600 - 1800 <2100
BOD (mg/L) 10000 - 12000 20 - 30 < 30
COD (mg/L) 14000 - 18000 175 - 200 < 250
 Contact Us
Head Office 85 , Industrial Area ‘A’
Ludhiana- 141003 India
Tele +91-161-2225531-35
Fax +91-161-2608784 , 2226929

Works: Village Fatehgarh Channa

Mansa Road Barnala-148101
Tele +91-1679-285285-88
Fax +91-1679-285292

Contact Persons Mr Varinder Gupta

varindergupta@iolcp.com

Mr. Rakesh Mahajan

rakeshmahajan@iolcp.com

Mr. R.K.Thukral
rkthukral@iolcp.com

Website : www.iolcp.com